Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Chronic Heart Failure

Free Subscription 06.03.2023 2 Am Heart J 2 Ann Thorac Surg 2 Circ Arrhythm Electrophysiol 1 Circ Genom Precis Med 2 Circ Heart Fail 3 Circulation 1 Clin Cardiol 2 Eur Heart J 13 Eur J Heart Fail 3 Heart 4 J Am Coll Cardiol 1 J Card Fail 4 J Cardiol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. UPSHAW JN, Parker S, Gregory D, Koethe B, et al
   The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) III Randomized Controlled Trial.
   Am Heart J. 2023 Feb 24:S0002-8703(23)00042-X. doi: 10.1016/j.ahj.2023.
   PubMed         Abstract available
   
   
2. YAKU H, Kato T, Morimoto T, Kaneda K, et al
   Rationale and Study design of the GOREISAN for Heart Failure (GOREISAN-HF) trial: A randomized clinical trial.
   Am Heart J. 2023 Feb 23:S0002-8703(23)00045-5. doi: 10.1016/j.ahj.2023.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

3. MALAS J, Chen Q, Akhmerov A, Tremblay LP, et al
   Experience With SynCardia Total Artificial Heart as a Bridge to Transplantation in 100 Patients.
   Ann Thorac Surg. 2023;115:725-732.
   PubMed         Abstract available
   
   
4. KUGO Y, Taira M, Watanabe T, Tominaga Y, et al
   Univentricular Conversion for Acquired Severe Right Ventricular Failure.
   Ann Thorac Surg. 2023;115:e75-e77.
   PubMed         Abstract available
   
   

   
   Circ Arrhythm Electrophysiol

5. OLIVETTI NQS, Sacilotto L, Wulkan F, Pessente GD, et al
   Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort.
   Circ Arrhythm Electrophysiol. 2023 Jan 31:e011391.
   PubMed         Abstract available
   
   
6. GALLOO X, Stassen J, Hirasawa K, Mertens BJA, et al
   Prognostic Implications of Right Ventricular Size and Function in Patients Undergoing Cardiac Resynchronization Therapy.
   Circ Arrhythm Electrophysiol. 2023;16:e011676.
   PubMed        
   
   

   
   Circ Genom Precis Med

7. LANFEAR DE, Luzum JA, She R, Li J, et al
   Validation of a Polygenic Score for Beta-Blocker Survival Benefit in Patients With Heart Failure Using the United Kingdom Biobank.
   Circ Genom Precis Med. 2023 Mar 3:e003835. doi: 10.1161/CIRCGEN.121.003835.
   PubMed        
   
   

   
   Circ Heart Fail

8. FUSCO F, Scognamiglio G, Merola A, Iannuzzi A, et al
   Safety and Efficacy of Sacubitril/Valsartan in Patients With a Failing Systemic Right Ventricle: A Prospective Single-Center Study.
   Circ Heart Fail. 2023;16:e009848.
   PubMed         Abstract available
   
   
9. TIE H, Zhu J, Akin S, Allen LA, et al
   Characteristics and Outcome of Patients With a History of Cancer Undergoing Durable Left Ventricular Assist Device Implantation.
   Circ Heart Fail. 2023;16:e009772.
   PubMed         Abstract available
   
   

   
   Circulation

10. HAHN VS, Petucci C, Kim MS, Bedi KC Jr, et al
    Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction.
    Circulation. 2023 Mar 1. doi: 10.1161/CIRCULATIONAHA.122.061846.
    PubMed         Abstract available
    
    
11. LEYVA F, Israel CW, Singh J
    Declining Risk of Sudden Cardiac Death in Heart Failure: Fact or Myth?
    Circulation. 2023;147:759-767.
    PubMed         Abstract available
    
    
12. SHELBAYA K, Claggett B, Dorbala P, Skali H, et al
    Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061396.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

13. YIN C, Li J, Yuan L
    Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
    Clin Cardiol. 2023 Mar 2. doi: 10.1002/clc.23994.
    PubMed        
    
    

    
    Eur Heart J

14. WOUTERS PC, van de Leur RR, Vessies MB, van Stipdonk AMW, et al
    Electrocardiogram-based deep learning improves outcome prediction following cardiac resynchronization therapy.
    Eur Heart J. 2023;44:680-692.
    PubMed         Abstract available
    
    
15. VOLPE M, Gallo G, Rubattu S
    Endocrine functions of the heart: from bench to bedside.
    Eur Heart J. 2023;44:643-655.
    PubMed         Abstract available
    
    

    
    Eur J Heart Fail

16. LEVI N, Moravsky G, Weitsman T, Amsalem I, et al
    A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons.
    Eur J Heart Fail. 2023;25:313-318.
    PubMed         Abstract available
    
    
17. PEIKERT A, Claggett BL, Kim K, Udell JA, et al
    Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial.
    Eur J Heart Fail. 2023;25:299-310.
    PubMed         Abstract available
    
    
18. WHEELER MT, Jacoby D, Elliott PM, Saberi S, et al
    Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.
    Eur J Heart Fail. 2023;25:260-270.
    PubMed         Abstract available
    
    
19. URIEL N, Milano C, Agarwal R, Lee S, et al
    Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis.
    Eur J Heart Fail. 2023;25:286-294.
    PubMed         Abstract available
    
    
20. OMOTE K, Verbrugge FH, Sorimachi H, Omar M, et al
    Central haemodynamic abnormalities and outcome in patients with unexplained dyspnoea.
    Eur J Heart Fail. 2023;25:185-196.
    PubMed         Abstract available
    
    
21. LIM HS, Yim IHW
    De novo aortic regurgitation related to left ventricular assist device therapy: the difficult questions in need of new perspectives.
    Eur J Heart Fail. 2023;25:295-298.
    PubMed        
    
    
22. DOMINGUEZ F, Cabrera E
    Mavacamten in obstructive hypertrophic cardiomyopathy - Are beta-blockers blocking part of its shine?
    Eur J Heart Fail. 2023;25:271-273.
    PubMed        
    
    
23. PATEL L, Keshvani N, Pandey A
    Are post-influenza vaccine reactions truly 'adverse'?
    Eur J Heart Fail. 2023;25:311-312.
    PubMed        
    
    
24. ABBASI MA, Borlaug BA
    Pulmonary vascular disease in heart failure with preserved ejection fraction: the evidence grows.
    Eur J Heart Fail. 2023 Feb 15. doi: 10.1002/ejhf.2800.
    PubMed        
    
    
25. GARD EK, Beale AL, Telles F, Silvestry FE, et al
    Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2023 Feb 27. doi: 10.1002/ejhf.2805.
    PubMed         Abstract available
    
    
26. GUSTAFSSON F, Damman K, Nalbantgil S, Van Laake LW, et al
    Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the ESC.
    Eur J Heart Fail. 2023 Feb 27. doi: 10.1002/ejhf.2814.
    PubMed         Abstract available
    
    
27. PACKER M
    Dosing of Iron Supplementation for Iron-Deficient Patients With Heart Failure: Should We Prefer More Intensive or Less Intensive Repletion Targets?
    Eur J Heart Fail. 2023 Feb 28. doi: 10.1002/ejhf.2816.
    PubMed        
    
    
28. BLUMER V, Truby LK, Zieroth S
    Sex Differences in Heart Failure: The Evolving Use of Biomarkers.
    Eur J Heart Fail. 2023 Feb 28. doi: 10.1002/ejhf.2817.
    PubMed        
    
    

    
    Heart

29. MARTIN DE MIGUEL I, Madhavan M, Miranda WR, Connolly HM, et al
    Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.
    Heart. 2022 Nov 11. pii: heartjnl-2022-321493. doi: 10.1136/heartjnl-2022-321493
    PubMed         Abstract available
    
    
30. WEIR RAP
    Management of hospitalised patients with heart failure admitted to non-cardiology services.
    Heart. 2023 Feb 27:heartjnl-2022-321720. doi: 10.1136/heartjnl-2022-321720.
    PubMed        
    
    
31. JORDAN C, Charman SJ, Batterham AM, Flynn D, et al
    Habitual physical activity levels of adults with heart failure: systematic review and meta-analysis.
    Heart. 2023 Feb 27:heartjnl-2022-321943. doi: 10.1136/heartjnl-2022-321943.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

32. PERIN EC, Borow KM, Henry TD, Mendelsohn FO, et al
    Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure.
    J Am Coll Cardiol. 2023;81:849-863.
    PubMed         Abstract available
    
    
33. MENASCHE P
    Mesenchymal Stromal Cell Therapy for Heart Failure: Never Stop DREAMing.
    J Am Coll Cardiol. 2023;81:864-866.
    PubMed        
    
    
34. WU J, Liang J, Huang Y
    Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed.
    J Am Coll Cardiol. 2023;81:e67.
    PubMed        
    
    
35. LAZARO I, Lupon J, Cediel G, Sala-Vila A, et al
    Reply: Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed.
    J Am Coll Cardiol. 2023;81:e69.
    PubMed        
    
    

    
    J Card Fail

36. CLARK KAA, Nanna MG
    Doing Harm by Doing No Harm? Resisting the urge to retire GDMT in older adults with heart failure.
    J Card Fail. 2023 Feb 23:S1071-9164(23)00058.
    PubMed        
    
    

    
    J Cardiol

37. SHINKAWA T, Ichihara Y, Saito S, Ishido M, et al
    Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
    J Cardiol. 2023;81:378-384.
    PubMed         Abstract available
    
    
38. JOKI Y, Konishi H, Takasu K, Minamino T, et al
    Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice.
    J Cardiol. 2023;81:347-355.
    PubMed         Abstract available
    
    
39. TSUTSUI H, Sakamaki H, Momomura SI, Sakata Y, et al
    Cost-effectiveness analysis of Empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-reduced trial.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00046-1. doi: 10.1016/j.jjcc.2023.
    PubMed         Abstract available
    
    
40. MISUMI K, Matsue Y, Nogi K, Fujimoto Y, et al
    Derivation and validation of a machine learning-based risk prediction model in patients with acute heart failure.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00045-X. doi: 10.1016/j.jjcc.2023.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: